[1]王 琰,王 静,张志明,等.卵巢肿瘤患者尿液中间皮素联合人附睾蛋白4检测及临床意义[J].陕西医学杂志,2019,(8):1088-1090.
　WANG Yan,WANG Jing,ZHANG Zhiming,et al.Predictive value between MSLN and HE4 in urine levels in patients with  early stage of epithelial ovarian cancer[J].,2019,(8):1088-1090.
点击复制

卵巢肿瘤患者尿液中间皮素联合人附睾蛋白4检测及临床意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年8期
页码:
1088-1090
栏目:
临床检验
出版日期:
2019-08-05

文章信息/Info

Title:
Predictive value between MSLN and HE4 in urine levels in patients with  early stage of epithelial ovarian cancer
文章编号:
DOI:10.3969/j.issn.1000-7377.2019.08.036
作者:
王 琰1; 王 静2; 张志明3; 程百茹1
1.西安交通大学附属西安市中心医院妇科（西安 710004）；2.陕西省肿瘤医院妇瘤科（西安 710061）；3.西安交通大学附属西安市中心医院检验科（西安710004）
Author(s):
WANG Yan; WANG Jing;  ZHANG Zhiming; et al.
Department of Gynecology,  〖HT5F〗Xi’an Central Hospital Affiliated to Xi’an Jiaotong University（Xi’an 710003）
关键词:
上皮性卵巢癌; 卵巢良性肿瘤; 诊断; 尿液; 间皮素; 人附睾蛋白4
Keywords:
Key words Epithelial ovarian cancer;  Benign ovarian tumor; Diagnosis;  Urine; Mesothelin; Humanepididymis secretory protein4
分类号:
R737.31
文献标志码:
A
摘要:
摘 要 目的：探讨卵巢肿瘤患者尿液中间皮素（MSLN）及人附睾蛋白4（HE4）含量及检测的临床意义。方法：73例卵巢肿瘤患者，其中上皮性卵巢癌Ⅰ～Ⅱ期12例，Ⅲ～Ⅳ期29例，卵巢良性肿瘤32例，同时以30例健康体检妇女作为正常对照组，采用酶联免疫吸附试验（ELISA法）检测三组尿液中MSLN、HE4含量，计算单项及联合检测在卵巢肿瘤诊断中的灵敏度、特异性及其相关性。结果：上皮性卵巢癌组尿液中MSLN、HE4浓度均高于良性肿瘤组和对照组（P<0.05）；卵巢癌Ⅰ～Ⅱ期与Ⅲ～Ⅳ期患者尿液中MSLN及HE4阳性率差异有统计学意义（P<0.05）;MSLN+HE4在卵巢癌尿液中联合检测的灵敏度、特异性均显著高于单一指标检测。结论：MSLN+HE4在尿液中的联合检测无创、便捷、有效、弥补单一指标检测的缺陷，这将为卵巢癌高危人群的早期筛查提供新的途径。
Abstract:
Abstract Objective：To study the expression level and its relationship of ovarian cancer tumor markers mesothelin(MSLN) and humanepididymis secretory protein4(HE4) in urine, and improving the early predictive value of epithelial ovarian cancer. Methods：73 patients with ovarian tumors were selected as subjects of study. One group patients with epithelial ovarian cancers，12 cases of the stages Ⅰ～Ⅱperiod，29 cases of the stages Ⅲ～Ⅳ period. The other group have 32 patients with ovarian benign tumor. 30 normal healthy women which were randomly selected by control group. Urine levels of MSLN and HE4 were detected by enzyme-linked immunosorbent assay technique in 73 ovarian tumor, which were divided into two groups by pathology. The sensitivity and specificity of the single and combined detection of urine levels of these markers in the diagnosis of ovarian cancer were calculated and compared. Results：The urine levels of MSLN and HE4 in ovarian cancer group were significantly higher than those of ovarian benign tumor and healthy controls (P＜0.05).The positive rates of MSLN and HE4 in urine were significantly higher inⅠ～Ⅱstage than in Ⅲ～Ⅳstage of ovarian cancer(P＜0.05).The sensitivity and accuracy of the joint detection in ovarian cancer group were obviously higher than that of the single parameter detection. Conclusion：It has been proved that the combined detection of tumor markers MSLN and HE4 in urine is noninvasive, convenient and effective, and can be used for screening high-risk ovarian cancer, which will also provide a new way for early screening of ovarian cancer.

参考文献/References:

[1] Hellstrom I, Heagerty PJ, Swisher EM, et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasm[J]. Cancer Letters,2010, 296(1):43-48.
[2] 王 琰, 杨聪莉, 程百茹, 等. 尿液 HE4 联合 CA125 检测对卵巢癌的价值初探[J]. 实用妇产科杂志, 2014, 30(3): 220-223.
[3] Badgwell D,Lu Z,Cole L,et al.Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin,urinary hCG free beta subunit and urinary hCG beta core fragment[J]. Gynecologic oncology,2007(3) :490-497.
[4] Hollevoet K,Speeckaert M,Decavele A,et al.Mesothelin levels in urine are affected by glomerular leakage and tubular reabsorption[J].Clin Lung Cancer,2012,13(6)：470-474.
[5] Sasaki A,Akita K,Ito F,et al.Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer[J].Int cancer,2015,136(8):1985-990.
[6] Hanaoka T,Hasegawa K,Kato T,et al.Correlation between tumor mesothelin expression and serum mesothelin in patients with epithelial ovarian carcinoma:a potential noninvasive biomarker for mesothelin-targeted therapy[J].Mol Diagn Ther,2017 ,21(2):187-198.
[7] Nassir M,Guan J,Luketina,et al. The role of HE4 for prediction recurrence in epithelial ovarian cancer patients-results from the OVCAD study[J]. Tumor Biology,2016,37(3):3009-3016.
[8] Pelissier A, Roulot A, Guéry B, et al.Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer[J]. Ovarian Res, 2016,27:9(1):61.
[9] Yuan CZ,Li RR,Yan S,et al. Prognostic value of HE4 in patients with ovarian cancer[J].Clin Chem Lab Med,2018,27,56(7):1026-1034.
[10] Liao JB,Yip YY,Swisher EM,et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates[J].Gynecol Oncol,2015,137(3)：430-435.
[11] Wang SQ,Akbas R,Demirci U,et al. Microchip ELISA coupled with cell phone to detect ovarian cancer HE4 biomarker in urine[J].Methods Mol Biol,2015,1256:111-121.
[12] Jia MM,Deng J,Cheng XL,et al. Diagnostic accuracy of urine HE4 in patients with ovarian cancar:a meta-analysis[J].Oncotarget,2016, 8(6)：9660-9671.

相似文献/References:

[1]孙红艳,王改华.不同手术方式治疗卵巢癌临床效果及对患者生育功能的影响[J].陕西医学杂志,2019,(2):213.
　SUN Hongyan,WANG Gaihua..Clinical effects of different surgical treatments on 125 patients with ovarian  cancer and their influence on reproductive function[J].,2019,(8):213.
[2]钟 亮,刘清壮,蔡茂德.III、IV期上皮性卵巢癌术后腹腔辅助化疗临床观察*[J].陕西医学杂志,2020,49(2):193.
　ZHONG Liang,LIU Qingzhuang,CAI Maode..Application of intraperitoneal chemotherapy in postoperative adjuvant treatment of stage Ⅲ and Ⅳ epithelial ovarian cancer[J].,2020,49(8):193.
[3]张晶晶,岳丽娟,王 莹,等.奥拉帕利联合奈达铂腹腔热灌注化疗治疗上皮性卵巢癌疗效观察[J].陕西医学杂志,2021,50(12):1566.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.025]
　ZHANG Jingjing,YUE Lijuan,WANG Ying,et al.Efficacy of olaparib combined with nedaplatin hyperthermic intraperitoneal chemotherapy in treatment of epithelial ovarian cancer[J].,2021,50(8):1566.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.025]
[4]孙丹丹,张 颖,马善波,等.膜相关环指蛋白7在上皮性卵巢癌组织和细胞中的表达及作用机制研究[J].陕西医学杂志,2024,(6):842.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.026]
　SUN Dandan,ZHANG Ying,MA Shanbo,et al.Expression and mechanism of membrane-associated ring finger protein 7 in epithelial ovarian cancer tissues and cells[J].,2024,(8):842.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.026]

更新日期/Last Update: 2019-08-13